What medications are Amanda on?
To start with, during and shortly after the transplant surgery, she received a drug called Campath that has been used as a chemotherapy drug for leukemia patients. It is actually a genetically engineered antibody that attacks a certain antibody in the B-cells in the body’s immune system, shutting the system down for about three weeks. The transplant team at Jackson has done research and found that administering Campath to transplant patients dramatically improves their chances, and lowers the levels of drugs needed later. Amanda’s main anti-rejection drug is Prograf, which is sort of a second-generation anti-rejection drug that has been used for about 15 years. It has less side effects than first generation drugs like Cyclosporin. She has also been on Rapamune, another newer anti-rejection drug that works a little differently than Prograf. When she had her two bouts of acute rejection, she was put on OKT3 each time, which is another engineered antibody that targets the T-cells in your
